Dr. Calabria is interested in the clinical evaluation of children at risk for bone disease. He has particular interest in metabolic bone disease/osteopenia of prematurity in at-risk neonates/infants.
The Lefebvre Lab advances the understanding of skeletal and neurodevelopmental syndromes. To this end, the team is decrypting mechanisms controlling the identity and activities of stem cells and differentiated cells governing these processes.
